Bath & Body Works (NYSE:BBWI) Price Target Raised to $21.00

Bath & Body Works (NYSE:BBWI) had its price target raised by Barclays from $20.00 to $21.00 in a research report report published on Monday,Benzinga reports. The firm currently has an equal weight rating on the stock.

Several other equities research analysts also recently weighed in on the company. Citigroup downgraded Bath & Body Works from a “buy” rating to a “neutral” rating and raised their price target for the stock from $21.00 to $25.00 in a report on Tuesday, February 17th. Wells Fargo & Company lowered their price target on Bath & Body Works from $33.00 to $25.00 and set an “overweight” rating for the company in a research report on Friday, November 21st. Guggenheim began coverage on Bath & Body Works in a research note on Tuesday, December 9th. They set a “neutral” rating on the stock. Jefferies Financial Group initiated coverage on Bath & Body Works in a research note on Wednesday, January 14th. They issued a “hold” rating and a $24.00 price objective for the company. Finally, Deutsche Bank Aktiengesellschaft assumed coverage on shares of Bath & Body Works in a report on Thursday, January 8th. They issued a “hold” rating and a $21.00 price target on the stock. Three investment analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $23.86.

Bath & Body Works Trading Up 2.3%

Shares of NYSE:BBWI opened at $22.94 on Monday. The business’s fifty day simple moving average is $22.32 and its 200-day simple moving average is $23.59. Bath & Body Works has a 12-month low of $14.27 and a 12-month high of $35.21. The company has a market capitalization of $4.70 billion, a PE ratio of 7.06, a P/E/G ratio of 0.97 and a beta of 1.48.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Wednesday, March 4th. The company reported $2.05 EPS for the quarter, beating the consensus estimate of $1.77 by $0.28. Bath & Body Works had a net margin of 9.50% and a negative return on equity of 47.35%. The business had revenue of $2.72 billion during the quarter, compared to analyst estimates of $2.59 billion. During the same period in the prior year, the firm posted $2.09 earnings per share. The company’s quarterly revenue was down 2.3% on a year-over-year basis. Bath & Body Works has set its Q1 2026 guidance at 0.240-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Research analysts predict that Bath & Body Works will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 6th. Stockholders of record on Friday, February 20th will be given a $0.20 dividend. The ex-dividend date is Friday, February 20th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.5%. Bath & Body Works’s payout ratio is 24.62%.

Hedge Funds Weigh In On Bath & Body Works

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Retirement Systems of Alabama raised its position in Bath & Body Works by 40.6% in the third quarter. Retirement Systems of Alabama now owns 772,324 shares of the company’s stock valued at $19,895,000 after purchasing an additional 223,089 shares during the period. Summit Investment Advisors Inc. purchased a new position in Bath & Body Works during the 1st quarter valued at about $1,292,000. Allianz Asset Management GmbH grew its position in Bath & Body Works by 58.8% in the 3rd quarter. Allianz Asset Management GmbH now owns 263,628 shares of the company’s stock valued at $6,791,000 after acquiring an additional 97,640 shares in the last quarter. Diamond Hill Capital Management Inc. lifted its position in shares of Bath & Body Works by 29.9% during the third quarter. Diamond Hill Capital Management Inc. now owns 369,452 shares of the company’s stock worth $9,517,000 after purchasing an additional 85,000 shares in the last quarter. Finally, Intech Investment Management LLC boosted its stake in shares of Bath & Body Works by 53.5% in the second quarter. Intech Investment Management LLC now owns 58,460 shares of the company’s stock valued at $1,751,000 after purchasing an additional 20,381 shares during the period. 95.14% of the stock is owned by hedge funds and other institutional investors.

Trending Headlines about Bath & Body Works

Here are the key news stories impacting Bath & Body Works this week:

• Positive Sentiment: Q4 beat on the top and bottom lines: adjusted EPS $2.05 vs. consensus ~$1.77 and revenue $2.72B vs. ~$2.59B; markets interpreted the beat as evidence the turnaround can work, helping shares trade higher. Bath & Body Works shares rise as Q4 beats estimates
• Positive Sentiment: Management says its “Consumer First” strategy and product/brand refocus are making progress, signaling potential medium‑term margin and sales benefits if execution continues — but they warned the shift will take time. Bath & Body Works Says Strategy Shift Making Progress But ‘Will Take Time’
• Neutral Sentiment: Analyst action: Deutsche Bank nudged its price target slightly higher to $22 (maintained Hold), a modest signal but not a clear catalyst. Deutsche Bank adjusts PT to $22 from $21
• Neutral Sentiment: Earnings call / analysis coverage published (transcript and quick takes) — useful for detail on same-store trends, promotions and inventory but largely confirm management’s cautious tone. Bath & Body Works Charts Turnaround Amid 2026 Squeeze
• Negative Sentiment: Guidance disappointed: FY 2026 EPS guide of $2.40–$2.65 below consensus (~$2.74) and Q1 guide of $0.24–$0.30 far below expectations — this is the primary near‑term negative catalyst as it signals tougher comps and a slower recovery. Company press release with results and 2026 guidance
• Negative Sentiment: Management warned annual sales will decline more steeply as consumers cut back on discretionary home‑fragrance and premium items — a demand risk that could pressure revenue and margins. Bath & Body Works forecasts steeper decline in annual sales (Reuters)
• Negative Sentiment: Legal risk: multiple law firms have filed or announced investigations/class actions alleging securities issues covering a June 2024–Nov 2025 period; this raises potential litigation costs, distraction and overhang on the stock. Bragar Eagel & Squire investor alert on BBWI

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.